DCB Therapy of Vulnerable Coronary Plaques | The DeBUT LRP Study

Monday, March 10, 2025

10:40 AM – 10:48 AM ET

Speaker(s)

Bimmer Claessen, MD

Interventional cardiologist
Amsterdam University Medical Center

Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Terminated); BBraun, Philips, Infraredx, Novo Nordisk: Grant/Research Support (Ongoing); Sanofi, Philips, BBraun, Abiomed, Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Terminated)

Disclosure(s):

Bimmer Claessen, MD: Amgen: Consulting Fees (e.g., advisory boards) (Terminated); BBraun, Philips, Infraredx, Novo Nordisk: Grant/Research Support (Ongoing); Sanofi, Philips, BBraun, Abiomed, Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Terminated)